ArticleFrontiers in oncology2021
Pembrolizumab Plus Chemotherapy or Anlotinib
Ya Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
24 papers cite it
this paperpooled ittrialcites it
ArticleFrontiers in oncology2021
Ya Chen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.